ARDS - Aridis Pharmaceuticals GAAP EPS of -$0.45 revenue of $0.29M August, 16 2022 04:22 PM Aridis Pharmaceuticals Inc. Aridis Pharmaceuticals press release ( NASDAQ: ARDS ): Q2 GAAP EPS of -$0.45. Revenue of $0.29M. otal cash, cash equivalents and restricted cash as of June 30, 2022 were approximately $8M. For further details see: Aridis Pharmaceuticals GAAP EPS of -$0.45, revenue of $0.29M